Updates In Diagnosis Of PTCL And The Role Of CD30 MedEdTalks

Content provided by Vindico Medical Education, Owen A. O'Connor, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Vindico Medical Education, Owen A. O'Connor, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

MedEdTalks - Oncology «
Updates in Diagnosis of PTCL and the Role of CD30

6y ago 16:22

MP3•Episode home

Peripheral T-cell lymphomas (PTCLs) are a highly heterogeneous and typically aggressive group of non-Hodgkin lymphomas. These rare tumors represent only 10% to 15% of non-Hodgkin lymphomas and are associated with 5-year survival rates as low as 20% in certain subtypes. Treatment of PTCL has historically consisted of conventional chemotherapy. However, the outcome is poor with this approach. Considerable effort in recent years has focused on identifying improved therapeutic approaches to target PTCLs with greater specificity. In this podcast, expert clinicians will discuss updates in diagnosis of PTCL and the role of CD30.

To obtain CME Credit, please go here: https://cme.healio.com/mededtalks/hematology-oncology/2019/10_october/mededtalks-oncology-updates-in-diagnosis-of-ptcl-and-the-role-of-cd30

14 episodes

#Science #Fitness #Medicine #Vindico Medical Education #Owen A. O'Connor #Lorenztrumper #Oncology #Owenoconnor #Ptcl #Timillidge #CME #MedEdTalks